Alzheimers disease is not simply a memory disease. It is a complex neurodegenerative process that often overlaps with insulin resistance, vascular disease, inflammation, mitochondrial stress, sleep disruption, and loss of metabolic resilience
Those are individualized, high-stakes conversations that require full disclosure, multidisciplinary collaboration, and explicit consent
High cost and insurance restrictions are common, with many plans requiring step therapy, higher BMI, or documented inability to lose weight by other methods before approval. Do GLP-1 drugs replace the need for arthritis or autoimmune medications
A recent study demonstrated that oral administration of NR could affect intestinal NAD + biosynthesis, mitigating ethanol-induced intestinal epithelial barrier damage by protecting mitochondrial function in a SIRT1-dependent manner [176]
Exercise, dietary changes and other strategies are also needed